FDA Warns Against Products Treating Opioid Withdrawal

Photo: U.S. Air Force / Mark R. W. Orders-Woempner

WASHINGTON – The U.S. Food and Drug Administration has officially warned a company about the illegal marketing and selling of products for opioid withdrawal.

The products are sold under the names Detoxoplex, Sinoplex and Migrenza.






According to EPH Technologies’ website, Detoxoplex can reduce “symptoms typically associated with withdrawal from opioid use.”

On Tuesday, the FDA sent a warning letter to EPH tTchnologies saying in part:





“This product has not been determined by FDA to be safe and effective for these uses. Further, this unproven treatment could cause patients to forgo or delay FDA-approved treatments for opioid addiction and withdrawal.”

Typically, symptoms of opioid withdrawal, including anxiety, nausea, vomiting and diarrhea.











It can be managed with medically assisted treatments such as Buprenorphine or Methadone.

 

Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.

 

Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

 

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.